characteristics.text: Y132F+K143R
characteristics.characteristic: Erg11 Genotype
characteristics.text: SAMN41569565
characteristics.characteristic: External Id
characteristics.text: R658G
characteristics.characteristic: Fks1 Genotype
characteristics.text: Conway Institute, University College Dublin
characteristics.characteristic: INSDC center name
characteristics.text: 2024-05-28T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-05-28T13:01:12.027Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS21446507
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Pathogen.cl
characteristics.characteristic: NCBI submission model
characteristics.text: Pathogen.cl.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS21446507
characteristics.characteristic: SRA accession
characteristics.text: Ege University Hospital, Turkey
characteristics.characteristic: collected_by
characteristics.text: 2022-03-22/2022-05-13
characteristics.characteristic: collection_date
characteristics.text: Turkey: Ege
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.characteristic: host
characteristics.text: Invasive candidiasis
characteristics.characteristic: host_disease
characteristics.text: A 4.5-year-old male patient previously diagnosed with Shah-Waardenburg syndrome and Hirschsprungs disease was transferred from another hospital to EUH on March 21, 2022 due to bilious vomiting and severe diarrhea admitted to EUH. The patient was febrile on March 22, 2022, and his urine and blood cultures were positive for C. parapsilosis. Treatment with fluconazole (80 mg daily for two days) was started on March 24, 2022, and then increased to 12 mg/kg on March 26, 2022 with the addition of liposomal amphotericin B; subsequently, the patient became afebrile on March 30, 2022. The patient had an indwelling venous catheter, which was removed on March 31, 2022, and fluconazole treatment was continued for another 14 days. The patient was discharged on April 13, 2022, and fluconazole treatment was continued for another 7 days. On the latest update (one month later), the patient returned to the hospital with persistent isolation of C. parapsilosis in multiple urine samples despite the long duration and high dosage of fluconazole treatment.
characteristics.characteristic: isolate
characteristics.text: blood sample
characteristics.characteristic: isolation_source
characteristics.text: 38.4567 N 27.2099 E
characteristics.characteristic: lat_lon
characteristics.text: Candida parapsilosis
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_5480
characteristics.characteristic: organism
characteristics.text: MDR6
characteristics.characteristic: strain
characteristics.text: Pathogen: clinical or host-associated sample from Candida parapsilosis
characteristics.characteristic: title